CVE:KSI kneat.com - KSI Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding kneat.com, inc. Please log in to your account or sign up in order to add this asset to your watchlist. C$4.25 +0.19 (+4.68%) (As of 11/12/2021) Add Compare Share Share Today's RangeC$4.10▼C$4.3050-Day RangeC$4.25▼C$4.2552-Week RangeC$2.00▼C$4.85Volume114,330 shsAverage Volume42,978 shsMarket CapitalizationC$325.27 millionP/E RatioN/ADividend YieldN/APrice TargetC$3.70 ProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlines About kneat.com (CVE:KSI) Stockkneat.com, inc. designs, develops, and supplies software for data and document management within regulated environments in the United States, Ireland, Canada, internationally. The company offers Kneat Gx platform, a configurable commercial off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries. Its platform is used in instrument, method, utility and facility, process, equipment, computer system, cold chain, and cleaning validation, as well commissioning and qualification, and electronic logbook management. It also provides software-related services, including training, installation, upgradation, consulting, and maintenance, as well as process mapping, project management, and other services. The company is headquartered in Limerick, Ireland.Read More Receive KSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for kneat.com and its competitors with MarketBeat's FREE daily newsletter. Email Address KSI Stock News HeadlinesJanuary 22, 2023 | americanbankingnews.comkneat.com (CVE:KSI) Stock Price Up 4.7%January 13, 2023 | finance.yahoo.comWe Think kneat.com (TSE:KSI) Can Afford To Drive Business GrowthJanuary 30, 2023 | Porter & Company (Ad)Is This The End of Capitalism?EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…December 20, 2022 | finance.yahoo.comKneat Adds IR Veteran to Lead Investor EngagementNovember 9, 2022 | finance.yahoo.comKneat Announces Record SaaS Revenue in Q3 2022October 27, 2022 | finance.yahoo.comTop Tier Fortune 500 Healthcare Company Selects KneatOctober 5, 2022 | ca.finance.yahoo.comkneat.com, inc. (KSI.TO)August 24, 2022 | finance.yahoo.comIs There An Opportunity With kneat.com, inc.'s (TSE:KSI) 23% Undervaluation?January 30, 2023 | Porter & Company (Ad)Is This The End of Capitalism?EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…August 13, 2022 | seekingalpha.comkneat.com, inc.'s (FBAYF) CEO Eddie Ryan on Q2 2022 Results - Earnings Call TranscriptAugust 4, 2022 | finance.yahoo.comCompanies Like kneat.com (TSE:KSI) Can Afford To Invest In GrowthJune 15, 2022 | finance.yahoo.comKneat Adds Accomplished Global Sales Leader to its Executive Team - Yahoo FinanceJune 14, 2022 | ca.finance.yahoo.comCYPRESS DEVELOPMENT DELIVERS SOLUTION FROM PILOT PLANT FOR TESTING PRODUCTION OF LITHIUM CARBONATE AND LITHIUM HYDROXIDE - Yahoo Canada FinanceJune 14, 2022 | ca.finance.yahoo.comSuspension of the vaccine mandates for domestic travellers, transportation workers and federal employees - Yahoo Canada FinanceJune 14, 2022 | ca.finance.yahoo.comRitchie Bros. expands offerings for oil & gas industry customers with new dedicated Energy team - Yahoo Canada FinanceJune 14, 2022 | ca.finance.yahoo.comGRYB Announces Acquisition of RAD Technologies, Dalkotech and Eco-trak - Yahoo Canada FinanceJune 14, 2022 | ca.finance.yahoo.comVERSABANK TO ACQUIRE OCC-CHARTERED NATIONAL US BANK, PROVIDING PLATFORM FOR GROWTH IN THE UNITED STATES - Yahoo Canada FinanceJune 14, 2022 | ca.finance.yahoo.comAdvocates of human rights in Cuba launch campaign to inform Canadians, Western Europeans on realities of repression and oppression against the Cuban people - Yahoo Canada FinanceJune 14, 2022 | ca.finance.yahoo.comHomeowners' Wallets Being Squeezed to Fund Expensive and Unpopular Police Transition - Yahoo Canada FinanceJune 14, 2022 | ca.finance.yahoo.comFusion Pharmaceuticals Presents Imaging Data from Cold Antibody Sub-Study in the Phase 1 Study of FPI-1434 - Yahoo Canada FinanceJune 14, 2022 | ca.finance.yahoo.comSOUNDEXCHANGE ANNOUNCES UNIFIED GLOBAL PUBLISHER SERVICES DIVISION TO SUPPORT MUSIC PUBLISHER COMMUNITY - Yahoo Canada FinanceJune 14, 2022 | finance.yahoo.comTravel and Tourism Industry Welcomes the Federal Government Decision to Suspend Vaccine Mandates; Calls for Full Removal of Vaccine Mandate and Remaining Restrictions to Streamline Passenger Experience - Yahoo FinanceJune 7, 2022 | forbes.comThe Future Of Manufacturing Execution Systems Is Simplicity - ForbesJune 1, 2022 | finance.yahoo.comMicrobion Corporation Announces Data Highlighting In Vitro Activity of Pravibismane in NTM, including Activity Against NTM Causing Intracellular Infections, to be Presented at the Colorado Mycobacteria Conference 2022 - Yahoo FinanceJune 1, 2022 | finance.yahoo.comSurge Copper Commences 2022 Exploration Program Testing Multiple New Targets Across Ootsa-Berg District - Yahoo FinanceJune 1, 2022 | finance.yahoo.comManulife Deepens ESG Focus with Launch of Impact Agenda - Yahoo FinanceMay 13, 2022 | finance.yahoo.comKneat Announces Record SaaS Revenue in Q1 2022 - Yahoo FinanceSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive KSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for kneat.com and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE Industry Health Information Services Sub-IndustryN/A SectorMedical Current SymbolCVE:KSI CUSIPN/A CIKN/A Webwww.kneat.com Phone353 6 120 3826FaxN/AEmployees60Year FoundedN/APrice Target and Rating Average Stock Price ForecastC$3.70 High Stock Price ForecastC$3.70 Low Stock Price ForecastC$3.70 Forecasted Upside/Downside-12.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth-93.55Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio24.11 Current Ratio2.47 Quick Ratio2.41 Sales & Book Value Annual SalesC$12.20 million Price / Sales26.66 Cash FlowC$0.29 per share Price / Cash Flow14.60 Book ValueC$0.46 per share Price / Book9.24Miscellaneous Outstanding Shares76,535,000Free FloatN/AMarket CapC$325.27 million OptionableNot Optionable BetaN/A Key ExecutivesMr. Edmund Ryan (Age 57)Co-Founder, CEO, Pres, Sales Director & Exec. Director Comp: $234.52kMr. Brian Ahearne (Age 52)Co-Founder, Chief Information Officer & Company Sec. Comp: $210.16kMr. Kevin Fitzgerald (Age 51)Co-founder, Chief Product Officer & Exec. Director Comp: $210.16kMr. Hugh Kavanagh (Age 59)Chief Financial Officer Comp: $209.53kMr. Keith HolmesChief Technology OfficerMs. Laura SweetVP of MarketingMore ExecutivesKey CompetitorsDialogue Health TechnologiesTSE:CAREWELL Health TechnologiesTSE:WELLProMetic Life SciencesTSE:PLIHLS TherapeuticsTSE:HLSFennec PharmaceuticalsTSE:FRXView All Competitors KSI Stock - Frequently Asked Questions Should I buy or sell kneat.com stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for kneat.com in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" KSI shares. View KSI analyst ratings or view top-rated stocks. What is kneat.com's stock price forecast for 2023? 1 Wall Street research analysts have issued 12-month price targets for kneat.com's stock. Their KSI share price forecasts range from C$3.70 to C$3.70. On average, they expect the company's stock price to reach C$3.70 in the next year. This suggests that the stock has a possible downside of 12.9%. View analysts price targets for KSI or view top-rated stocks among Wall Street analysts. How have KSI shares performed in 2023? kneat.com's stock was trading at C$4.25 at the start of the year. Since then, KSI shares have increased by 0.0% and is now trading at C$4.25. View the best growth stocks for 2023 here. What other stocks do shareholders of kneat.com own? Based on aggregate information from My MarketBeat watchlists, some companies that other kneat.com investors own include Brookfield Property Partners (BPY.UN), Eldorado Gold (ELD), NVIDIA (NVDA), Yamana Gold (YRI), Aurora Cannabis (ACB), Boeing (BA), Intercontinental Exchange (ICE), Lightspeed Commerce (LSPD), Polo Resources (POL). What is kneat.com's stock symbol? kneat.com trades on the Canadian Venture Exchange (CVE) under the ticker symbol "KSI." How do I buy shares of kneat.com? Shares of KSI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is kneat.com's stock price today? One share of KSI stock can currently be purchased for approximately C$4.25. How much money does kneat.com make? kneat.com (CVE:KSI) has a market capitalization of C$325.27 million and generates C$12.20 million in revenue each year. How can I contact kneat.com? The official website for the company is www.kneat.com. The company can be reached via phone at 353 6 120 3826. This page (CVE:KSI) was last updated on 1/30/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.